Colquhoun David
Department of Pharmacology, University College London, London WC1E 6BT.
BMJ. 2007 Mar 10;334(7592):507. doi: 10.1136/bmj.39122.551250.BE.
Demand for complementary and alternative medicine is high despite limited evidence. believe that a thorough review by NICE would benefit the NHS and patients, but argues that it cannot afford to re-examine evidence that has shown little benefit
尽管证据有限,但对补充和替代医学的需求仍然很高。有人认为,英国国家卫生与临床优化研究所(NICE)进行全面审查将使英国国民健康服务体系(NHS)和患者受益,但也有人认为,它无力重新审视那些益处不大的证据。